Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): A 2-year randomized controlled trial.
Chang YeAlexandra EmeryChang YeStewart B HarrisSonja M ReichertNatalia McInnesUlagamadesan VenkatesanKevin E ThorpeCaroline Kaercher KramerBernard ZinmanPublished in: Diabetes, obesity & metabolism (2021)
Although initial induction IIT induces metabolic improvement, subsequent repeat courses of IIT every 3 months do not further enhance the effect of MET maintenance therapy on beta-cell function.